Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
Abstract
Glioblastoma is an aggressive brain tumour with a patient median survival of approximately 14 months. The development of innovative treatment strategies to increase the life span and quality of life of patients is hence essential. This requires the use of appropriate glioblastoma models for preclinical testing, which faithfully reflect human cancers. The aim of this study was to establish glioblastoma patient-derived xenografts (PDXs) by...
Paper Details
Title
Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
Published Date
Apr 3, 2020
Journal
Volume
12
Issue
4
Pages
871 - 871
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History